Overview
BVS market data
Price History
BVS price chart
Valuation & Profitability
- P/E (TTM)
- 41.01 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.33 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.68 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 4.9% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $6.26 – $15.89 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.2B · P/B 3.34 · P/S 2.03.
Company News
Deal Dispatch: Bending Spoons Acquires Airtable, Bain Capital Buys Gong Cha Global, Salad and Go BankruptcyBenzinga · Aug 7, 2026, 5:12 PM
Bioventus shares are trading higher after the company reported strong Q2 financial results and announced a review of strategic alternatives.Benzinga · Aug 5, 2026, 3:00 PM
8-K filing — Bioventus Inc. (BVS)SEC EDGAR · Aug 5, 2026, 11:40 AM
Bioventus Q2 Adj. EPS $0.22, Inline, Sales $153.208M Miss $155.640M EstimateBenzinga · Aug 5, 2026, 11:34 AM
Bioventus Affirms FY2026 Adj EPS Guidance of $0.75-$0.79 vs $0.78 Est; Affirms FY2026 Sales Guidance of $600.000M-$610.000M vs $605.756M EstBenzinga · Aug 5, 2026, 11:31 AM
Under the Radar: 3 Boring Small Caps That Could Return 10xBenzinga · Jul 29, 2026, 7:29 PM
Why Forte Biosciences Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving PremarketBenzinga · Jul 27, 2026, 9:09 AM
Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare ConferenceGlobenewswire Inc · Jun 2, 2026, 11:15 AM
Transcript: Bioventus Q1 2026 Earnings Conference CallBenzinga · Jun 1, 2026, 10:46 AM
Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing ItBenzinga · May 22, 2026, 3:15 PM